The North America intraoperative neuromonitoring market is expected to reach US$ 1,874.02 million by 2027 from US$ 1,029.17 million in 2019; it is estimated to grow at a CAGR of 7.9% from 2020 to 2027.
Factors such as rising incidences of neurological disorders and increasing technological advancements in the field of neuromonitoring are expected to propel the growth of the market. However, lack of skilled professionals is the major factor hindering the market growth.
Intraoperative neurophysiological monitoring (IOM) is an integral part of most of the surgical procedures. It has been widely used to prevent the neurological damage caused during number of surgeries, identify neural structures and thereby prevent post-operative impairments. IOM employs a wide range of modalities, which includes motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electroencephalography (EEG), electromyography, brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs).
Advancements in neuromonitoring have helped the surgeons minimize the risks during surgery when the central nervous system (CNS) is at risk. Many advanced products are being launched in the field of neuromonitoring, further driving the growth of the market. For instance, in February 2019, Alphatec Holdings Inc. has received 510(k) clearance from the FDA for its automated SafeOp neuromonitoring system. It offers real-time intraoperative nerve location and health assessment. To date, The SafeOp technology has been used in over 1,000 surgeries to identify nerve injury and has proved reliability in monitoring peripheral nerves in spine surgery.
Advancements in intraoperative neuromonitoring have resulted in the development of technologically advanced systems to improve patient monitoring during a surgical procedure. For instance, in February 2018, the Centers of Medicare & Medicaid Services approved SpineTRACK Registry by NuVasive, Inc. This device allows surgeons to use real-time data reports to make on-time medical decisions during surgeries. In addition, in October 2017, SpecialtyCare launched OptimizeOR, which is a robust operating room management analytics solution to help hospitals to improve their perioperative performance. Moreover, the market players in the market are also engaged in a strategic partnership with several companies to expand their geographic reach. For instance, in December 2017, NuVasive, Inc. acquired SafePassage, an intraoperative neuromonitoring service provider. This has strengthened the company’s IONM business.
North America is witnessing the growing number of COVID-19 cases; The patients suffering from critical surgeries such as spinal surgery, neurosurgery, and ENT surgery need physical attention and need to perform procedures in the clinics. The procedure includes Intraoperative Neuromonitoring, by systems, services and accessories. As the surgical treatment, procedures are directly contacted with patients’ that has a possible risk of infections, for the preventing the spread of COVID-19 it is requested to maintain social distancing as there is a greater risk of being infected with coronavirus due to direct exposure to oral fluids of the patients. Therefore, it is likely to affect the intraoperative neuromonitoring market owing to the above mention points.
Mexico Intraoperative neuromonitoring Market, Revenue and Forecast to 2027 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION
By Product
- Systems
- Accessories
- Services
By Source
- Insourced Monitoring
- Outsourced Monitoring
By Modality
- Motor Evoked Potentials
- Somatosensory Evoked Potentials
- Electroencephalography
- Electromyography
- Brainstem Auditory Evoked Potentials
- Visual Evoked Potentials
By Application
- Spinal Surgery
- Neurosurgery
- Vascular Surgery
- ENT Surgery
- Orthopedic Surgery
- Other Surgeries
By End User
- Hospitals
- Ambulatory Surgical Centers
By Country
- US
- Canada
- Mexico
Company Profiles
- Accurate Monitoring
- Computational Diagnostics, Inc
- IntraNerve Neuroscience Holdings, LLC
- Natus Medical Incorporated
- NuVasive, Inc
- SpecialtyCare
- Moberg Research, Inc
North America Intraoperative Neuromonitoring Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 1,029.17 Million |
Market Size by 2027 | US$ 1,874.02 Million |
Global CAGR (2020 - 2027) | 7.9% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset



Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Product, Source, Application, Modality, and End User, and Country

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
US, Canada
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - North America Intraoperative Neuromonitoring Market
- Accurate Monitoring
- Computational Diagnostics, Inc
- IntraNerve Neuroscience Holdings, LLC
- Natus Medical Incorporated
- NuVasive, Inc
- SpecialtyCare
- Moberg Research, Inc